Our intellectual capital is a cornerstone of our asset portfolio, comprising a robust bank of patents, intellectual property, trademarks, publications, and licenses. This intellectual capital reflects our commitment to innovation and thought leadership in the fields of preclinical research, drug development, and nutraceuticals. Our extensive portfolio of patents and intellectual property protects our groundbreaking discoveries and proprietary technologies, ensuring a competitive edge in the marketplace. Trademarks safeguard our brand identity, reinforcing the trust and recognition associated with our products. Our publications in reputable scientific journals underscore our contributions to the global body of knowledge, while our strategic licenses facilitate the commercialization of our innovations. By fostering collaborations with industry leaders and research institutions, we maximize the impact and reach of our intellectual assets. Together, these elements of intellectual capital not only secure our market position but also drive continuous advancement and value creation within our BioEngine and VedaEngine frameworks, propelling us toward a future of sustained growth and innovation.
